Variations of the corona HDL:albumin ratio determine distinct effects of amorphous SiO2 nanoparticles on monocytes and macrophages in serum

Nanomedicine

Volumn 9, Issue 16, 2014, Pages 2481-2497

  Fedeli, Chiara ^a   Segat, Daniela ^a,b   Tavano, Regina ^a   De Franceschi, Giorgia ^a   De Laureto, Patrizia Polverino ^a   Lubian, Elisa ^a   Selvestrel, Francesco ^a   Mancin, Fabrizio ^a   Papini, Emanuele ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b Baschirotto Institute for Rare Diseases   (Italy)

Author keywords

amorphous silica nanoparticle; HDL; macrophage; monocyte; nanoparticle protein corona; pyroptosis

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HUMAN SERUM ALBUMIN; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; SILICON DIOXIDE; ALBUMINOID; HIGH DENSITY LIPOPROTEIN; NANOPARTICLE; PLASMA PROTEIN;

ACIDIFICATION; ARTICLE; CELL DEATH; CELL MEMBRANE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOLYSIS; CYTOTOXICITY TEST; DISPERSION; FETAL CALF SERUM; HEMOLYSIS; HUMAN; HUMAN CELL; HYDRODYNAMICS; LYSOSOME; MACROPHAGE; MONOCYTE; NUCLEOTIDE SEQUENCE; PARTICLE SIZE; PROTEIN PURIFICATION; SERUM; ZETA POTENTIAL; ANIMAL; BLOOD; BOVINE; CHEMISTRY; DRUG EFFECTS; METABOLISM;

ALBUMINS; ANIMALS; BLOOD PROTEINS; CATTLE; CELL DEATH; HUMANS; LIPOPROTEINS, HDL; MACROPHAGES; MONOCYTES; NANOPARTICLES; SILICON DIOXIDE;

EID: 84908378757     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.14.22     Document Type: Article

References (56)

1. Fedeli C, Selvestrel F, Tavano R, Segat D, Mancin F, Papini E. Catastrophic infammatory death of monocytes and macrophages by overtaking of a critical dose of endocytosed synthetic amorphous silica nanoparticles/serum protein complexes. Nanomedicine (Lond.) 8(7) 1101-1126 (2012).
2. Broz P, von Moltke J, Jones J W, Vance RE, Monack DM. Differential requirement for caspase-1 autoproteolysis in pathogen-induced cell death and cytokine processing. Cell Host Microbe 8(6), 471-483 (2010).
3. Miao EA, Rajan JV, Aderem A. Caspase-1-induced pyroptotic cell death. Immunol. Rev. 243(1), 206-214 (2011).
4. Shao W, Yeretssian G, Doiron K, Hussain SN, Saleh M. The caspase-1 digestome identifes the glycolysis pathway as a target during infection and septic shock. J. Biol. Chem. 282(50), 36321-36329 (2007).
5. Martinon F, Mayor A, Tschopp J. The infammasomes: guardians of the body. Annu. Rev. Immunol. 27, 229-265 (2009).
6. Bauernfeind F, Ablasser A, Bartok E et al. Infammasomes: current understanding and open questions. Cell. Mol. Life Sci. 68(5), 765-783 (2011).
7. Morishige T, Yoshioka Y, Inakura H et al. The effect of surface modifcation of amorphous silica particles on NLRP3 infammasome mediated IL-1beta production, ROS production and endosomal rupture. Biomaterials 31(26), 6833-6842 (2010).
8. Meunier E, Coste A, Olagnier D et al. Double-walled carbon nanotubes trigger IL-1beta release in human monocytes through NLRP3 infammasome activation. Nanomedicine 8(6), 987-995 (2012).
9. Lunov O, Syrovets T, Loos C et al. Differential uptake of functionalized polystyrene nanoparticles by human macrophages and a monocytic cell line. ACS Nano. 5(3), 1657-1669 (2011).
10. Hornung V, Bauernfeind F, Halle A et al. Silica crystals and aluminum salts activate the NALP3 infammasome through phagosomal destabilization. Nat. Immunol. 9(8), 847-856 (2008).
11. Sandberg WJ, Lag M, Holme JA et al. Comparison of non-crystalline silica nanoparticles in IL-1beta release from macrophages. Part. Fibre Toxicol. 9, 32 (2012).
12. Sharp FA, Ruane D, Claass B et al. Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 infammasome. Proc. Natl Acad. Sci. USA 106(3), 870-875 (2009).
13. Reisetter AC, Stebounova LV, Baltrusaitis J et al. Induction of infammasome-dependent pyroptosis by carbon black nanoparticles. J. Biol. Chem. 286(24), 21844-21852 (2011).
14. Walkey CD, Chan WC. Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment. Chem. Soc. Rev. 41(7), 2780-2799 (2012).
15. Aggarwal P, Hall JB, McLeland CB, Dobrovolskaia MA, McNeil SE. Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic effcacy. Adv. Drug Deliv. Rev. 61(6), 428-437 (2009).
16. Mortensen NP, Hurst GB, Wang W, Foster CM, Nallathamby PD, Retterer ST. Dynamic development of the protein corona on silica nanoparticles: composition and role in toxicity. Nanoscale 5(14), 6372-6380 (2013).
17. Monopoli MP, Aberg C, Salvati A, Dawson KA. Biomolecular coronas provide the biological identity of nanosized materials. Nat. Nanotechnol. 7(12), 779-786 (2012).
18. Casals E, Pfaller T, Duschl A, Oostingh GJ, Puntes V. Time evolution of the nanoparticle protein corona. ACS Nano. 4(7), 3623-3632 (2010).
19. Nagayama S, Ogawara K, Fukuoka Y, Higaki K, Kimura T. Time-dependent changes in opsonin amount associated on nanoparticles alter their hepatic uptake characteristics. Int. J. Pharm. 342(1-2), 215-221 (2007).
20. Jansch M, Stumpf P, Graf C, Ruhl E, Muller RH. Adsorption kinetics of plasma proteins on ultrasmall superparamagnetic iron oxide (USPIO) nanoparticles. Int. J. Pharm. 428(1-2), 125-133 (2012).
21. Tenzer S, Docter D, Kuharev J et al. Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology. Nat. Nanotechnol. 8(10), 772-781 (2013).
22. Owens DE 3rd, Peppas NA. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int. J. Pharm. 307(1), 93-102 (2006).
23. Lesniak A, Fenaroli F, Monopoli MP, Aberg C, Dawson KA, Salvati A. Effects of the presence or absence of a protein corona on silica nanoparticle uptake and impact on cells. ACS Nano. 6(7), 5845-5857 (2012).
24. Ehrenberg MS, Friedman AE, Finkelstein JN, Oberdorster G, McGrath JL. The infuence of protein adsorption on nanoparticle association with cultured endothelial cells. Biomaterials 30(4), 603-610 (2009).
25. Barran-Berdon AL, Pozzi D, Caracciolo G et al. Time evolution of nanoparticle-protein corona in human plasma: relevance for targeted drug delivery. Langmuir 29(21), 6485-6494 (2013).
26. Deng ZJ, Liang M, Monteiro M, Toth I, Minchin RF. Nanoparticle-induced unfolding of fbrinogen promotes Mac-1 receptor activation and infammation. Nat. Nanotechnol. 6(1), 39-44 (2011).
27. Costantini LM, Gilberti RM, Knecht DA. The phagocytosis and toxicity of amorphous silica. PLoS ONE 6(2), e14647 (2011).
28. Park EJ, Park K. Oxidative stress and proinfammatory responses induced by silica nanoparticles in vivo and in vitro. Toxicol. Lett. 184(1), 18-25 (2009).
29. Chang JS, Chang KL, Hwang DF, Kong ZL. In vitro cytotoxicitiy of silica nanoparticles at high concentrations strongly depends on the metabolic activity type of the cell line. Environ. Sci. Technol. 41(6), 2064-2068 (2007).
30. Peters R, Kramer E, Oomen AG et al. Presence of nano-sized silica during in vitro digestion of foods containing silica as a food additive. ACS Nano. 6(3), 2441-2451 (2012).
31. Tavano R, Franzoso S, Cecchini P et al. The membrane expression of Neisseria meningitidis adhesin A (NadA) increases the proimmune effects of MenB OMVs on human macrophages, compared with NadA-OMVs, without further stimulating their proinfammatory activity on circulating monocytes. J. Leukoc. Biol. 86(1), 143-153 (2009).
32. Zinchuk V, Zinchuk O, Okada T. Quantitative colocalization analysis of multicolor confocal immunofuorescence microscopy images: pushing pixels to explore biological phenomena. Acta Histochem. Cytochem. 40(4), 101-111 (2007).
33. Forgac M. Vacuolar ATPases: rotary proton pumps in physiology and pathophysiology. Nat. Rev. Mol. Cell Biol. 8(11), 917-929 (2007).
34. Bowman EJ, Siebers A, Altendorf K. Baflomycins: a class of inhibitors of membrane ATPases from microorganisms, animal cells, and plant cells. Proc. Natl Acad. Sci. USA 85(21), 7972-7976 (1988).
35. Rabuffetti M, Sciorati C, Tarozzo G, Clementi E, Manfredi AA, Beltramo M. Inhibition of caspase-1-like activity by Ac-Tyr-Val-Ala-Asp-chloromethyl ketone induces long-lasting neuroprotection in cerebral ischemia through apoptosis reduction and decrease of proinfammatory cytokines. J. Neurosci. 20(12), 4398-4404 (2000).
36. Ferrari D, Pizzirani C, Adinolf E et al. The P2X7 receptor: a key player in IL-1 processing and release. J. Immunol. 176(7), 3877-3883 (2006).
37. + release. Am. J. Physiol. Cell. Physiol. 286(5), C1100-8 (2004).
38. Netea MG, Simon A, van de Veerdonk F, Kullberg BJ, Van der Meer JW, Joosten LA. IL-1beta processing in host defense: beyond the infammasomes. PLoS Pathog. 6(2), e1000661 (2010).
39. Perregaux DG, McNiff P, Laliberte R, Conklyn M, Gabel CA. ATP acts as an agonist to promote stimulus-induced secretion of IL-1 beta and IL-18 in human blood. J. Immunol. 165(8), 4615-4623 (2000).
40. Lynch I, Cedervall T, Lundqvist M, Cabaleiro-Lago C, Linse S, Dawson KA. The nanoparticle-protein complex as a biological entity; a complex fuids and surface science challenge for the 21st century. Adv. Colloid Interface Sci. 134-135, 167-174 (2007).
41. Lartigue L, Wilhelm C, Servais J et al. Nanomagnetic sensing of blood plasma protein interactions with iron oxide nanoparticles: impact on macrophage uptake. ACS Nano. 6(3), 2665-2678 (2012).
42. Sabuncu AC, Grubbs J, Qian S, Abdel-Fattah TM, Stacey MW, Beskok A. Probing nanoparticle interactions in cell culture media. Colloids Surf. B Biointerfaces 95, 96-102 (2012).
43. Maiorano G, Sabella S, Sorce B et al. Effects of cell culture media on the dynamic formation of protein-nanoparticle complexes and infuence on the cellular response. ACS Nano. 4(12), 7481-7491 (2010).
44. Dell'Orco D, Lundqvist M, Oslakovic C, Cedervall T, Linse S. Modeling the time evolution of the nanoparticle-protein corona in a body fuid. PLoS ONE 5(6), e10949 (2010).
45. Cedervall T, Lynch I, Foy M et al. Detailed identifcation of plasma proteins adsorbed on copolymer nanoparticles. Angew. Chem. Int. Ed. Engl. 46(30), 5754-5756 (2007).
46. Forte TM, Bell-Quint JJ, Cheng F. Lipoproteins of fetal and newborn calves and adult steer: a study of developmental changes. Lipids 16(4), 240-245 (1981).
47. Shi J, Hedberg Y, Lundin M, Odnevall Wallinder I, Karlsson HL, Moller L. Hemolytic properties of synthetic nano-and porous silica particles: the effect of surface properties and the protection by the plasma corona. Acta Biomater. 8(9), 3478-3490 (2012).
48. Sahai N. Biomembrane phospholipid-oxide surface interactions: crystal chemical and thermodynamic basis. J. Colloid Interface Sci. 252(2), 309-319 (2002).
49. Tenzer S, Docter D, Rosfa S et al. Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: a comprehensive quantitative proteomic analysis. ACS Nano. 5(9), 7155-7167 (2011).
50. Hellstrand E, Lynch I, Andersson A et al. Complete high-density lipoproteins in nanoparticle corona. FEBS J. 276(12), 3372-3381 (2009).
51. Lundqvist M, Stigler J, Elia G, Lynch I, Cedervall T, Dawson KA. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc. Natl. Acad. Sci. USA 105(38), 14265-14270 (2008).
52. Wang F, Yu L, Monopoli MP et al. The biomolecular corona is retained during nanoparticle uptake and protects the cells from the damage induced by cationic nanoparticles until degraded in the lysosomes. Nanomedicine 9(8), 1159-1168 (2013).
53. Seshadri S, Duncan MD, Hart JM, Gavrilin MA, Wewers MD. Pyrin levels in human monocytes and monocyte-derived macrophages regulate IL-1beta processing and release. J. Immunol. 179(2), 1274-1281 (2007).
54. Salvati A, Pitek AS, Monopoli MP et al. Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. Nat. Nanotechnol. 8(2), 137-143 (2013).
55. Lesniak A, Campbell A, Monopoli MP, Lynch I, Salvati A, Dawson KA. Serum heat inactivation affects protein corona composition and nanoparticle uptake. Biomaterials 31(36), 9511-9518 (2010).
56. Laurent S, Burtea C, Thirifays C, Rezaee F, Mahmoudi M. Signifcance of cell 'observer' and protein source in nanobiosciences. J. Colloid Interface Sci. 392, 431-445 (2013).